Dear Dr. J. Douglas White

We want to thank you for the opportunity to respond to the issue raised by Dr. Carver\'s letter about our manuscript "Cardiac injury is associated with mortality and critically-ill pneumonia in COVID-19: A meta-analysis", recently published in "American Journal of Emergency Medicine" \[[@bb0005]\].

We would also thank Dr. Carver and her colleagues at The Usher Institute, the University of Edinburgh, for their interest in our paper and commenting on our paper \[[@bb0005]\]. This is a meta-analysis which suggest that cardiac injury is associated with clinical outcomes, namely: mortality, need for ICU care and severity of disease in COVID-19. Because the clinical spectrum of COVID-19 widely ranges from a very mild to critically ill cases, and the previous studies only reported epidemiological findings limited to pneumonia; there was a need to disclose the association of cardiac injury and clinical outcome in such disease.

In her letter to the editor, Dr. Carver notes potential concerns on the composite outcome of respiratory failure, ARDS and sepsis defined by Wu C et al. \[[@bb0010]\], and she concerned that those composite outcomes would underpin an inaccurate conclusion that cardiac injury is not significantly associated with increased risk of ARDS in COVID-19 in our study {1\]. We would also be grateful to Dr. Carver et al, for their interest in our paper and for taking time to express their concerns.

Wu et al. study included a composite outcome of respiratory failure, ARDS, or sepsis in their paper \[[@bb0010]\]. We included them in the analysis because a large proportion of the composite outcome is attributed to respiratory failure; it is hard to diagnose ARDS per se separately in the context of respiratory failure. A previous study showed that the overall agreement on the diagnosis of ARDS in patients with respiratory failure was only 31%. Additionally, disagreement about the diagnosis of ARDS is quite common and can be partly explained by the difficulty of dichotomizing subjects along a continuous spectrum of ARDS manifestations \[[@bb0015]\]. The authors of the study concluded that pneumonia and shock were most likely to receive a diagnosis of ARDS by a consensus of physicians aligns with the current understanding of the pathophysiology of this syndrome \[[@bb0015]\]. This indicates that the three entities may be a part of *one clinical spectrum* in patients with respiratory failure. Even, the current Berlin definition of ARDS has only moderate interrater reliability when applied to patients with respiratory failure \[[@bb0020]\]. Consequently, the current analysis suggests that rather than being a deterministic phenomenon, patients with clinical features of ARDS have a broad spectrum of clinical manifestations and severity.

Moreover, we have attempted to contact the corresponding author \[[@bb0010]\] for specific details on ARDS; unfortunately, they do not respond. Hence, we decided to include the variable in our analysis. Despite not achieving statistical significance, there is a trend towards increased ARDS due to cardiac injury in Wu et al. study; therefore a larger sample size may demonstrate a positive result.
